Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00980460
Title Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

hepatoblastoma

Therapies

Irinotecan + Temsirolimus + Vincristine Sulfate

Cisplatin + Fluorouracil + Vincristine Sulfate

Doxorubicin

Age Groups: child
Covered Countries USA | CAN


No variant requirements are available.